tiprankstipranks
NexgenRx Inc (TSE:NXG)
TSXV:NXG
Canadian Market

NexgenRx (NXG) Cash flow

11 Followers

NexgenRx Cash Flow

TSE:NXG's free cash flow for Q4 2023 was C$―. For the 2023 fiscal year, TSE:NXG's free cash flow was decreased by C$-559.45K and operating cash flow was C$-526.46K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
C$ 1.20MC$ 1.28MC$ 1.07MC$ 3.82MC$ 2.65MC$ 1.05M
Investing Cash Flow
C$ -302.65KC$ -248.41KC$ -506.61KC$ -1.37MC$ -1.08MC$ -956.81K
Financing Cash Flow
C$ -797.48KC$ -919.06KC$ -1.11MC$ -939.79KC$ -1.30MC$ -395.45K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ 6.44MC$ 1.88MC$ 1.77MC$ 2.32MC$ 801.97KC$ 527.09K
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
C$ 187.50KC$ 62.50K--C$ 100.00KC$ 0.00
Issuance Of Debt
C$ -82.64KC$ -79.23KC$ -208.22KC$ -809.32KC$ 0.00C$ 1.32M
Repayment Of Debt
C$ -61.91K-C$ -208.22KC$ -809.32KC$ -1.40MC$ -1.72M
Free Cash Flow
C$ 1.48M-C$ 559.45KC$ 2.45MC$ 1.58MC$ 88.88K
Domestic Sales
------
Foreign Sales
------
Currency in CAD

NexgenRx Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis